134 related articles for article (PubMed ID: 9598126)
1. Differentiation and reduction of intracellular GTP levels in HL-60 and U937 cells upon treatment with IMP dehydrogenase inhibitors.
Inai K; Tsutani H; Yamauchi T; Nakamura T; Ueda T
Adv Exp Med Biol; 1998; 431():549-53. PubMed ID: 9598126
[No Abstract] [Full Text] [Related]
2. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase.
Sokoloski JA; Blair OC; Sartorelli AC
Cancer Res; 1986 May; 46(5):2314-9. PubMed ID: 2870796
[TBL] [Abstract][Full Text] [Related]
3. A decrease in the intracellular guanosine 5'-triphosphate concentration is necessary for granulocytic differentiation of HL-60 cells, but growth cessation and differentiation are not associated with a change in the activation state of Ras, the transforming principle of HL-60 cells.
Pilz RB; Huvar I; Scheele JS; Van den Berghe G; Boss GR
Cell Growth Differ; 1997 Jan; 8(1):53-9. PubMed ID: 8993834
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of IMP dehydrogenase prevent sindbis virus replication and reduce GTP levels in Aedes albopictus cells.
Malinoski F; Stollar V
Virology; 1981 Apr; 110(2):281-9. PubMed ID: 6111860
[No Abstract] [Full Text] [Related]
5. Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism.
Sokoloski JA; Sartorelli AC
Mol Pharmacol; 1985 Dec; 28(6):567-73. PubMed ID: 2867464
[TBL] [Abstract][Full Text] [Related]
6. GTP depletion induced by IMP dehydrogenase inhibitors blocks RNA-primed DNA synthesis.
Catapano CV; Dayton JS; Mitchell BS; Fernandes DJ
Mol Pharmacol; 1995 May; 47(5):948-55. PubMed ID: 7746281
[TBL] [Abstract][Full Text] [Related]
7. Selective guanosine phosphate deficiency in hepatoma cells induced by inhibitors of IMP dehydrogenase.
Kaiser WA; Herrmann B; Keppler DO
Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1503-10. PubMed ID: 6108911
[TBL] [Abstract][Full Text] [Related]
8. Consequences of inhibition of guanine nucleotide synthesis by mycophenolic acid and virazole.
Lowe JK; Brox L; Henderson JF
Cancer Res; 1977 Mar; 37(3):736-43. PubMed ID: 837373
[TBL] [Abstract][Full Text] [Related]
9. Low GTP induces PKC-beta-dependent myeloid cell differentiation.
Tsutani H; Inai K; Yamauchi T; Nakamura T; Huberman E; Ueda T
Adv Exp Med Biol; 1998; 431():429-32. PubMed ID: 9598104
[No Abstract] [Full Text] [Related]
10. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
[TBL] [Abstract][Full Text] [Related]
11. Cell differentiation and altered IMP dehydrogenase expression induced in human T-lymphoblastoid leukemia cells by mycophenolic acid and tiazofurin.
Kiguchi K; Collart FR; Henning-Chubb C; Huberman E
Exp Cell Res; 1990 Mar; 187(1):47-53. PubMed ID: 1967583
[TBL] [Abstract][Full Text] [Related]
12. Biological effects of inhibition of guanine nucleotide synthesis by mycophenolic acid in cultured neuroblastoma cells.
Cass CE; Lowe JK; Manchak JM; Henderson JF
Cancer Res; 1977 Sep; 37(9):3314-20. PubMed ID: 195725
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition and induction of phenotypic alterations in MCF-7 breast cancer cells by an IMP dehydrogenase inhibitor.
Sidi Y; Panet C; Wasserman L; Cyjon A; Novogrodsky A; Nordenberg J
Br J Cancer; 1988 Jul; 58(1):61-3. PubMed ID: 2901850
[No Abstract] [Full Text] [Related]
14. IMP dehydrogenase inhibitors reduce intracellular tetrahydrobiopterin levels through reduction of intracellular GTP levels. Indications of the regulation of GTP cyclohydrolase I activity by restriction of GTP availability in the cells.
Hatakeyama K; Harada T; Kagamiyama H
J Biol Chem; 1992 Oct; 267(29):20734-9. PubMed ID: 1356983
[TBL] [Abstract][Full Text] [Related]
15. Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis.
Balzarini J; Karlsson A; Wang L; Bohman C; Horská K; Votruba I; Fridland A; Van Aerschot A; Herdewijn P; De Clercq E
J Biol Chem; 1993 Nov; 268(33):24591-8. PubMed ID: 7901217
[TBL] [Abstract][Full Text] [Related]
16. Guanosine-5'-triphosphate increases in red blood cells of heart transplant recipients treated with mycophenolate mofetil.
Griesmacher A; Weigel G; Seebacher G; Müller MM
Adv Exp Med Biol; 2000; 486():139-43. PubMed ID: 11783471
[No Abstract] [Full Text] [Related]
17. Inosine 5'-monophosphate dehydrogenase inhibition by mycophenolic acid impairs maturation and function of dendritic cells.
Dubsky PC; Friedl J; Stift A; Bachleitner-Hofmann T; Jakesz R; Gnant MF; Weigel G
Clin Chim Acta; 2006 Feb; 364(1-2):139-47. PubMed ID: 16051207
[TBL] [Abstract][Full Text] [Related]
18. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis.
Jayaram HN; Cooney DA; Grusch M; Krupitza G
Curr Med Chem; 1999 Jul; 6(7):561-74. PubMed ID: 10390601
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibitors of GTP synthesis impede exocytotic insulin release from intact rat islets.
Metz SA; Rabaglia ME; Pintar TJ
J Biol Chem; 1992 Jun; 267(18):12517-27. PubMed ID: 1352288
[TBL] [Abstract][Full Text] [Related]
20. Induction of erythroid differentiation in K562 cells by inhibitors of inosine monophosphate dehydrogenase.
Yu J; Lemas V; Page T; Connor JD; Yu AL
Cancer Res; 1989 Oct; 49(20):5555-60. PubMed ID: 2571408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]